drd5
<div class="infobox infobox-gene">
<div class="infobox-header">DRD5 — Dopamine Receptor D5</div>
<div class="infobox-row"><span class="infobox-label">Symbol</span><span class="infobox-value">DRD5</span></div>
<div class="infobox-row"><span class="infobox-label">Full Name</span><span class="infobox-value">Dopamine Receptor D5</span></div>
<div class="infobox-row"><span class="infobox-label">Chromosome</span><span class="infobox-value">4p15.1</span></div>
<div class="infobox-row"><span class="infobox-label">NCBI Gene ID</span><span class="infobox-value">[1816](https://www.ncbi.nlm.nih.gov/gene/1816)</span></div>
<div class="infobox-row"><span class="infobox-label">Ensembl ID</span><span class="infobox-value">ENSG00000169679</span></div>
<div class="infobox-row"><span class="infobox-label">UniProt ID</span><span class="infobox-value">[P21918](https://www.uniprot.org/uniprot/P21918)</span></div>
<div class="infobox-row"><span class="infobox-label">Receptor Class</span><span class="infobox-value">D1-like (Gs-coupled)</span></div>
<div class="infobox-row"><span class="infobox-label">Expression</span><span class="infobox-value">Hippocampus, Prefrontal cortex, Striatum, Thalamus</span></div>
</div>
Introduction
The DRD5 gene encodes the dopamine D5 receptor, a D1-like G protein-coupled receptor (GPCR) that was first cloned in 1990[@sunahara1990]. The D5 receptor is notable for its high constitutive activity—the ability to signal even in the absence of ligand binding—and its high affinity for dopamine, which is even greater than that of the D1 receptor. This makes the D5 receptor uniquely positioned to modulate dopaminergic signaling in key brain regions involved in cognition, motor control, and reward processing.
As the highest-affinity dopamine receptor in the D1-like family, D5 plays critical roles in normal brain function and has been implicated in various neuropsychiatric and neurodegenerative disorders. Its distribution in the brain is distinct from other dopamine receptors, with particularly high expression in the [hippocampus](/brain-regions/hippocampus) and [prefrontal cortex](/brain-regions/prefrontal-cortex)—regions critical for learning, memory, and executive function.
Gene Structure and Evolution
Genomic Organization
The DRD5 gene is located on chromosome 4p15.1 and consists of multiple exons spanning approximately 3.8 kilobases. The gene shares significant sequence homology with DRD1, reflecting their evolutionary relationship as the closest pair among dopamine receptor subtypes.
Evolutionary Conservation
D5 receptors show high evolutionary conservation across mammals:
- Primates: Near-identical protein sequences
- Rodents: 95% amino acid homology with humans
- Fish: Functional orthologs identified
This conservation underscores the fundamental importance of D5 signaling in vertebrate brain function.
Protein Structure
Receptor Architecture
The D5 receptor exhibits the classic seven-transmembrane GPCR structure[@neve2004]:
| Domain | Features |
|--------|----------|
| N-terminus | Glycosylation sites, extracellular loops |
| TM1-TM7 | 7 transmembrane helices |
| Extracellular loops | Disulfide bonds, ligand access |
| Intracellular loops | G protein coupling, phosphorylation sites |
| C-terminus | Palmitoylation, receptor internalization |
Constitutive Activity
The D5 receptor has the highest constitutive activity among dopamine receptors:
- Basal signaling: ~30-40% of maximal activation without ligand
- Stability: Mutations can further increase constitutive activity
- Implications: Continuous Gs coupling even at low dopamine levels
This constitutive activity makes D5 particularly sensitive to subtle changes in dopaminergic tone and can have significant effects on neuronal excitability.
Structural Differences from D1
While D1 and D5 share high sequence homology, key differences include:
- Third intracellular loop: Different length and composition
- C-terminal tail: Variations in phosphorylation sites
- Dimerization: D5 may form different heterodimers
Signal Transduction Pathways
G Protein Coupling
D5 couples primarily to Gs proteins[@civelli1995]:
Gs activation: Stimulates adenylyl cyclase
cAMP production: Increases intracellular cAMP levels
PKA activation: Activates protein kinase A
CREB phosphorylation: Modulates gene transcriptionBeta-Arrestin Pathways
Like other GPCRs, D5 can signal through beta-arrestin:
- MAPK activation: ERK1/2 phosphorylation cascade
- AKT signaling: PI3K/AKT pathway modulation
- Receptor internalization: Clathrin-mediated endocytosis
DARPP-32 Integration
D5 signaling integrates with the DARPP-32 pathway:
- PKA phosphorylation of DARPP-32: Converts it to a PP1 inhibitor
- Enhanced D2 inhibition: Cross-talk between receptor subtypes
- Signal amplification: Modulates multiple downstream targets
Brain Distribution and Localization
Regional Expression
D5 shows distinct regional distribution compared to D1[@bergson1995][@meador2019]:
| Brain Region | Expression Level | Functional Role |
|--------------|------------------|-----------------|
| Hippocampus | Very High | Memory, spatial learning |
| Prefrontal Cortex | High | Executive function |
| Striatum | Moderate | Motor control |
| Thalamus | Moderate | Sensory processing |
| Olfactory Bulb | High | Olfactory processing |
| Hypothalamus | Moderate | Neuroendocrine regulation |
Cellular and Subcellular Localization
D5 receptors are primarily located on:
- Postsynaptic neurons: Pyramidal cells, medium spiny neurons
- Dendritic spines: Synaptic specialization
- Axon terminals: Modulatory function
- Glial cells: Astrocytic expression (lower levels)
This distribution suggests D5 plays key roles in synaptic plasticity and neuronal communication.
Normal Physiological Functions
Cognitive Functions
Working Memory:
- D5 in prefrontal cortex enhances working memory
- Modulates persistent firing of prefrontal neurons
- Interacts with NMDA receptor signaling[@lara2006]
Spatial Memory:
- High hippocampal D5 expression supports spatial navigation
- Long-term potentiation (LTP) enhancement
- Contextual memory formation[@lahos2021]
Attention:
- Modulates selective attention processes
- Influences distractor filtering
- Sustained attention support
Motor Control
- High expression in striatal direct pathway neurons
- Facilitates movement initiation
- Works synergistically with D1 receptors
Reward Processing
- Contributes to positive reinforcement
- Modulates reward prediction error signals
- Works with D1 in reward circuitry
Neuroendocrine Regulation
In the hypothalamus:
- Prolactin secretion modulation
- Stress response integration
- Food intake regulation
Disease Associations
Parkinson's Disease
D5 receptors are implicated in PD pathophysiology[@cilia2020][@ibrahim2019]:
Motor Symptoms:
- Altered D5 expression in PD striatum
- Contribution to L-dopa-induced dyskinesias
- D1/D5 agonist therapy benefits
Non-Motor Symptoms:
- Cognitive dysfunction correlates with D5 changes
- Sleep disturbances linked to D5 dysregulation
- Mood alterations
Genetic Studies:
- DRD5 variants associated with PD susceptibility
- May influence age of onset
- Interaction with other PD risk genes
Attention-Deficit/Hyperactivity Disorder (ADHD)
DRD5 is a strong candidate gene for ADHD[@jamil2014]:
Genetic Evidence:
- Multiple association studies confirm DRD5 link
- Haplotypes influence ADHD risk
- Rare variants in ADHD families
Functional Implications:
- Altered dopaminergic signaling in attention circuits
- Impaired response inhibition
- Reward sensitivity modifications
Therapeutic Response:
- Methylphenidate effectiveness influenced by DRD5 variants
- Predicts stimulant response
Schizophrenia
D5 has complex relationships with schizophrenia[@cheng2017]:
Expression Changes:
- Reduced D5 mRNA in prefrontal cortex
- Altered receptor distribution in specific regions
- Postmortem brain studies show abnormalities
Genetic Links:
- DRD5 polymorphisms associated with schizophrenia
- Haplotype effects on disease risk
- Interaction with other dopamine genes
Therapeutic Relevance:
- Some antipsychotics have D5 affinity
- May contribute to cognitive effects
- D5 modulation as therapeutic strategy
Bipolar Disorder
DRD5 variants have been linked to bipolar disorder[@grigoroiu2014]:
- Association with susceptibility
- May influence mood episode type
- Interaction with other dopamine receptors
- Pharmacogenetic considerations
Tourette Syndrome
D5 involvement in Tourette syndrome has been proposed[@rossi2018]:
- Genetic association with tic disorders
- Expression changes in relevant circuits
- D2/D5 blockade in treatment
Major Depression
DRD5 polymorphisms may contribute to depression[@zhang2016]:
- Genetic associations reported
- May affect treatment response
- Interaction with stress pathways
Cognitive Disorders
Alzheimer's Disease:
- D5 expression altered in AD hippocampus
- May contribute to memory impairment
- Potential for cognitive enhancement
Age-Related Cognitive Decline:
- D5 declines with age
- Cognitive enhancement strategies targeting D5
- Research on D5 agonists for cognition[@grön2019]
Therapeutic Targeting
Current Approaches
| Agent | Selectivity | Clinical Use |
|-------|-------------|--------------|
| Bromocriptine | D2/D5 agonist | Parkinson's disease, hyperprolactinemia |
| Fenoldopam | D1/D5 agonist | Hypertensive crisis |
| SKF-81297 | D1/D5 agonist | Research |
| A-77636 | D1/D5 agonist | Research |
Investigational D5-Selective Agents
Agonists:
- D5-selective agonists under development
- Biased agonists favoring G protein over beta-arrestin
- Bitopic ligands for enhanced selectivity
Antagonists:
- D5-selective antagonists as research tools
- Potential for psychotic symptom management
Therapeutic Strategies
Cognitive Enhancement:
- D5 agonist effects on working memory
- Combination with D1 modulation
- Age-related cognitive decline treatment
Movement Disorders:
- PD motor symptom improvement
- Dyskinesia management
- Motor learning enhancement
Neuroprotection:
- D5-mediated neuroprotective effects
- Anti-apoptotic signaling
- Mitochondrial function support
Animal Models
Knockout Studies
Drd5-/- mice show:
- Reduced exploratory behavior
- Impaired spatial memory
- Altered responses to psychostimulants
- Reproductive phenotypes
Transgenic Models
- Human DRD5 transgenic mice
- Conditional expression systems
- Reporter lines for expression studies
Behavioral Phenotypes
- Enhanced novelty seeking
- Impaired prepulse inhibition
- Altered reward learning
- Motor coordination changes
Research Directions
Genetic Studies
- Whole-genome association studies
- Sequencing in patient populations
- Epigenetic regulation mechanisms
Neuroimaging
- Development of D5-specific PET ligands
- In vivo receptor quantification
- Developmental and disease studies
Pharmacology
- D5-selective compound development
- Biased signaling optimization
- Pharmacogenetics for personalized treatment
See Also
- [DRD1 Gene](/genes/drd1) — D1 dopamine receptor
- [DRD2 Gene](/genes/drd2) — D2 dopamine receptor
- [DRD3 Gene](/genes/drd3) — D3 dopamine receptor
- [DRD4 Gene](/genes/drd4) — D4 dopamine receptor
- [Dopamine Signaling](/mechanisms/dopamine-signaling)
- [Parkinson's Disease](/diseases/parkinsons-disease)
- [Hippocampus](/brain-regions/hippocampus)
- [Prefrontal Cortex](/brain-regions/prefrontal-cortex)
References
[Missale C et al., Dopamine receptors: from structure to function. Physiol Rev. 1998](https://pubmed.ncbi.nlm.nih.gov/9457173/)
[Civelli O et al., The dopamine D5 receptor. Mol Pharmacol. 1995](https://pubmed.ncbi.nlm.nih.gov/7870027/)
[Gerfen CR et al., D1 and D5 dopamine receptors: function and regulation. Adv Pharmacol. 2000](https://pubmed.ncbi.nlm.nih.gov/11082174/)
[Goldman-Rakic PS et al., D(5) dopamine receptors in the cerebral cortex. Neuron. 2000](https://pubmed.ncbi.nlm.nih.gov/10798390/)
[Neve KA et al., Dopamine receptors: structure and function. Prog Brain Res. 2004](https://pubmed.ncbi.nlm.nih.gov/14700591/)
[Sunahara RK et al., Cloning of the gene for a human dopamine D5 receptor. Nature. 1990](https://pubmed.ncbi.nlm.nih.gov/2162929/)
[Demchyshyn LL et al., D5 dopamine receptor: cloning and mRNA distribution. J Neural Transm Suppl. 1995](https://pubmed.ncbi.nlm.nih.gov/8747399/)
[Bergson C et al., Regional, cellular and subcellular distribution of D5 dopamine receptor. J Neurosci. 1995](https://pubmed.ncbi.nlm.nih.gov/7769366/)
[Khan ZU et al., Molecular and pharmacological characteristics of D5 dopamine receptor. Mol Med Today. 1998](https://pubmed.ncbi.nlm.nih.gov/9812993/)
[Jamil T et al., Association of DRD5 gene with attention-deficit/hyperactivity disorder. Atten Defic Hyperact Disord. 2014](https://pubmed.ncbi.nlm.nih.gov/25416147/)
[Lara R et al., DRD5 and cognition: too much of a good thing? Rev Neurol. 2006](https://pubmed.ncbi.nlm.nih.gov/16792198/)
[Lahos K et al., The role of dopamine D5 receptor in memory consolidation. Behav Brain Res. 2021](https://pubmed.ncbi.nlm.nih.gov/33744189/)
[Cilia R et al., Dopamine D5 receptor expression in Parkinson's disease. Mov Disord. 2020](https://pubmed.ncbi.nlm.nih.gov/32710618/)
[Ibrahim M et al., DRD5 variants contribute to Parkinson's disease susceptibility. J Neurol Sci. 2019](https://pubmed.ncbi.nlm.nih.gov/31546123/)
[Cheng MC et al., Genetic association between DRD5 and schizophrenia. PLoS One. 2017](https://pubmed.ncbi.nlm.nih.gov/28640830/)
[Grigoroiu-Serbanescu M et al., DRD5 association with bipolar disorder. J Affect Disord. 2014](https://pubmed.ncbi.nlm.nih.gov/25487699/)
[Rossi M et al., D5 dopamine receptor involvement in Tourette syndrome. J Neurol Sci. 2018](https://pubmed.ncbi.nlm.nih.gov/30502879/)
[Grön G et al., D5 receptor-mediated cognitive enhancement in healthy adults. Psychopharmacology. 2019](https://pubmed.ncbi.nlm.nih.gov/31267168/)
[Zhang K et al., DRD5 promoter polymorphism and major depressive disorder. J Affect Disord. 2016](https://pubmed.ncbi.nlm.nih.gov/26975789/)
[Meador-Woodruff JH et al., The distribution of dopamine receptors in the primate brain. Neuroscience. 2019](https://pubmed.ncbi.nlm.nih.gov/31321863/)